Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

CRISPR technology leaps from lab to industry

Nature (2013)Cite this article

Subjects

Scientists launch company to develop the therapeutic potential of gene-snipping enzymes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Helen Shen
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Precision gene editing paves way for transgenic monkeys 2013-Nov-06

French institute prepares for gene-therapy push 2012-Jan-25

Gene-therapy enzymes make unpredicted errors 2011-Aug-07

Targeted gene editing enters clinic 2011-Mar-01

Protein engineering: The fate of fingers 2008-Sep-10

Human gene therapy worth the risk 2001-Apr-20

The zinc finger nuclease monopoly

Related external links

Sangamo BioSciences

Feng Zhang

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, H. CRISPR technology leaps from lab to industry. Nature (2013). https://doi.org/10.1038/nature.2013.14299

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2013.14299

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research